Figure 1.
Outline of the MRI exams acquired for patients of the I-SPY1 TRIAL dataset undergoing neoadjuvant chemotherapy. MRIs related to timepoints T1 and T2 were analyzed for the prediction of three-year breast cancer recurrence.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.